Lead party: Aleyo Capital (Pty) Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Delta Pharmaceuticals (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals, Medical Supplies · Countries of operation: Botswana
Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity · Strategy: Buyout · Instrument: Equity · Equity stake: 1% · Fund: Aleyo Growth Fund I
Lead investor/buyer: Aleyo Capital (Pty) Limited · Investors/buyers: Aleyo Capital (Pty) Limited · Sellers: Harshadkumar Patel
Legal advisers: not identified in the source record.
Source: announced 28 November 2023. Original announcement: competitionauthority.co.bw.


